William Blair Comments on Biogen’s Q2 Earnings (NASDAQ:BIIB)
Biogen Inc. (NASDAQ:BIIB – Free Report) – Research analysts at William Blair boosted their Q2 2025 earnings estimates for Biogen in a research report issued to clients and investors on Wednesday, February 12th. William Blair analyst M. Minter now anticipates that the biotechnology company will earn $4.20 per share for the quarter, up from their […]
Biogen Inc. (NASDAQ:BIIB – Free Report) – Research analysts at William Blair boosted their Q2 2025 earnings estimates for Biogen in a research report issued to clients and investors on Wednesday, February 12th. William Blair analyst M. Minter now anticipates that the biotechnology company will earn $4.20 per share for the quarter, up from their […]
